Jessica R Perley, ARNP | |
148 E Hersey St, Ashland, OR 97520-1359 | |
(541) 326-4777 | |
(541) 708-6372 |
Full Name | Jessica R Perley |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 4 Years |
Location | 148 E Hersey St, Ashland, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639759335 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LP2300X | Nurse Practitioner - Primary Care | 5380079081 (Kansas) | Secondary |
363L00000X | Nurse Practitioner | 202200981NP-PP (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Medford Home Care | Medford, OR | Home health agency |
Asante Ashland Community Hospital | Ashland, OR | Hospital |
Asante Rogue Regional Medical Center | Medford, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Monarque Health And Wellness Llc | 3678832151 | 5 |
News Archive
Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).
Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
TWi Biotechnology, Inc. announced that it has completed the patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis during urate-lowering therapy. This randomized, double-blind, placebo-controlled Phase II study is conducted in 8 major medical centers in Taiwan.
Given the difficulty regarding pancreatic biopsy procedures, a research group led by Dr. Chatzipantelis investigates the relatively novel preoperative and bloodless technique of image-guided fine-needle aspiration (FNA), and explores its value in diagnosing pancreatic lesions.
› Verified 4 days ago
Entity Name | Monarque Health And Wellness Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245789338 PECOS PAC ID: 3678832151 Enrollment ID: O20180108001687 |
News Archive
Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).
Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
TWi Biotechnology, Inc. announced that it has completed the patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis during urate-lowering therapy. This randomized, double-blind, placebo-controlled Phase II study is conducted in 8 major medical centers in Taiwan.
Given the difficulty regarding pancreatic biopsy procedures, a research group led by Dr. Chatzipantelis investigates the relatively novel preoperative and bloodless technique of image-guided fine-needle aspiration (FNA), and explores its value in diagnosing pancreatic lesions.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica R Perley, ARNP 148 E Hersey St, Ashland, OR 97520-1359 Ph: (541) 326-4777 | Jessica R Perley, ARNP 148 E Hersey St, Ashland, OR 97520-1359 Ph: (541) 326-4777 |
News Archive
Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).
Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
TWi Biotechnology, Inc. announced that it has completed the patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis during urate-lowering therapy. This randomized, double-blind, placebo-controlled Phase II study is conducted in 8 major medical centers in Taiwan.
Given the difficulty regarding pancreatic biopsy procedures, a research group led by Dr. Chatzipantelis investigates the relatively novel preoperative and bloodless technique of image-guided fine-needle aspiration (FNA), and explores its value in diagnosing pancreatic lesions.
› Verified 4 days ago
Ms. Kellyn Marshall, RN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 208 Oak St Ste 208, Ashland, OR 97520 Phone: 541-656-2279 Fax: 541-314-9627 | |
Juliana Ayres, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 Oak St Apt 4, Ashland, OR 97520 Phone: 541-422-3851 Fax: 541-325-4827 | |
Christa Elane Degrazia, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 146 Clear Creek Dr, Suite 350, Ashland, OR 97520 Phone: 541-494-8888 Fax: 541-494-1300 | |
Donna M Markle, RN PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Ohsu School Of Nursing, 1250 Siskiyou Blvd, Ashland, OR 97520 Phone: 541-552-6729 Fax: 541-552-6055 | |
Mrs. Barbara Denys Hinds, GNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 560 Catalina Dr, Ashland, OR 97520 Phone: 541-201-4800 Fax: 541-201-4815 | |
Kamara Marie Dodd, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 644 Ray Ln, Ashland, OR 97520 Phone: 541-404-4485 Fax: 541-225-4884 | |
Nicholas Scott Normandin, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 148 E Hersey St, Ashland, OR 97520 Phone: 541-326-4777 |